Home›Companies›Healthcare›Novodx

Novodx Corp.

Updated Oct 27, 2026·Latest SEC filing Mar 18, 2025·Suggest an edit

About Novodx

Novodx is a private company based in Tequesta, Florida, incorporated in 2022 in Delaware. It has reported $2,339,895 raised in three offerings on Form D since November 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 6, 2025Mar 18, 2025$200,000of $700K target11$18,182Convertible Loan NoteRule 506(b)Form D ↗
Apr 11, 2024Feb 26, 2025$1,139,895fully sold11$103KConvertible Loan NoteRule 506(b)Form D ↗
Sep 21, 2023Nov 15, 2023$1,000,000fully sold10$100KConvertible NoteRule 506(b)Form D ↗
Total, three offerings$2,339,895

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Novodx's Form D filed Mar 18, 2025.

NT
Nancy Torres
Executive officer
MW
BP
Brett Parent
Director

Earlier filings also listed Nancy Torres Kaufman (executive officer and director, last listed Nov 2023).

Sources

  1. SECNOVODX Corp filing history